| Dr Jeanne Marie Busch, DO | |
|
620 John Paul Jones Cir, Portsmouth, VA 23708-2111 | |
| (757) 953-0399 | |
| Not Available |
| Full Name | Dr Jeanne Marie Busch |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 27 Years |
| Location | 620 John Paul Jones Cir, Portsmouth, Virginia |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1578526851 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 0102201799 (Virginia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Chesapeake Regional Medical Center | Chesapeake, VA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mid-atlantic Womens Care Plc | 8820998156 | 140 |
News Archive
Genaera Corporation has announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to squalamine, an intravenously administered, first in class, small molecule anti-angiogenic drug for the treatment of "wet" age-related macular degeneration (AMD).
Scientists have made an important advance in understanding the genetic processes that give flowers, leaves and plants their bright colours. The knowledge could lead to a range of benefits, including better understanding of the cancer-fighting properties of plant pigments and new, natural food colourings.
Reuters reports that health care overhaul currently being considered in Congress "elevates the job of running the government's $700-billion Medicare agency to new heights and all but guarantees a political battle over filling the post."
EKOS Corporation announced today that Dr. David W. Newell, Co–Executive Director, Swedish Neuroscience Institute (Seattle, WA) presented a SNI clinical study known as ‘SLEUTH' (Safety of Lysis with Ultrasound in the Treatment of Intracerebral (ICH) and Intraventricular Hemorrhage (IVH) at the American Heart Association International Stroke Conference (San Antonio, TX).
› Verified 8 days ago
| Entity Name | Mid-atlantic Womens Care Plc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1699365072 PECOS PAC ID: 8820998156 Enrollment ID: O20040115000607 |
News Archive
Genaera Corporation has announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to squalamine, an intravenously administered, first in class, small molecule anti-angiogenic drug for the treatment of "wet" age-related macular degeneration (AMD).
Scientists have made an important advance in understanding the genetic processes that give flowers, leaves and plants their bright colours. The knowledge could lead to a range of benefits, including better understanding of the cancer-fighting properties of plant pigments and new, natural food colourings.
Reuters reports that health care overhaul currently being considered in Congress "elevates the job of running the government's $700-billion Medicare agency to new heights and all but guarantees a political battle over filling the post."
EKOS Corporation announced today that Dr. David W. Newell, Co–Executive Director, Swedish Neuroscience Institute (Seattle, WA) presented a SNI clinical study known as ‘SLEUTH' (Safety of Lysis with Ultrasound in the Treatment of Intracerebral (ICH) and Intraventricular Hemorrhage (IVH) at the American Heart Association International Stroke Conference (San Antonio, TX).
› Verified 8 days ago
| Entity Name | Mid-atlantic Womens Care Plc |
|---|---|
| Entity Type | Part B Supplier - Mammography Center |
| Entity Identifiers | NPI Number: 1699365072 PECOS PAC ID: 8820998156 Enrollment ID: O20080611000246 |
News Archive
Genaera Corporation has announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to squalamine, an intravenously administered, first in class, small molecule anti-angiogenic drug for the treatment of "wet" age-related macular degeneration (AMD).
Scientists have made an important advance in understanding the genetic processes that give flowers, leaves and plants their bright colours. The knowledge could lead to a range of benefits, including better understanding of the cancer-fighting properties of plant pigments and new, natural food colourings.
Reuters reports that health care overhaul currently being considered in Congress "elevates the job of running the government's $700-billion Medicare agency to new heights and all but guarantees a political battle over filling the post."
EKOS Corporation announced today that Dr. David W. Newell, Co–Executive Director, Swedish Neuroscience Institute (Seattle, WA) presented a SNI clinical study known as ‘SLEUTH' (Safety of Lysis with Ultrasound in the Treatment of Intracerebral (ICH) and Intraventricular Hemorrhage (IVH) at the American Heart Association International Stroke Conference (San Antonio, TX).
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jeanne Marie Busch, DO 3832 Three Ships Ldg, Virginia Beach, VA 23455-1675 Ph: (757) 270-7635 | Dr Jeanne Marie Busch, DO 620 John Paul Jones Cir, Portsmouth, VA 23708-2111 Ph: (757) 953-0399 |
News Archive
Genaera Corporation has announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to squalamine, an intravenously administered, first in class, small molecule anti-angiogenic drug for the treatment of "wet" age-related macular degeneration (AMD).
Scientists have made an important advance in understanding the genetic processes that give flowers, leaves and plants their bright colours. The knowledge could lead to a range of benefits, including better understanding of the cancer-fighting properties of plant pigments and new, natural food colourings.
Reuters reports that health care overhaul currently being considered in Congress "elevates the job of running the government's $700-billion Medicare agency to new heights and all but guarantees a political battle over filling the post."
EKOS Corporation announced today that Dr. David W. Newell, Co–Executive Director, Swedish Neuroscience Institute (Seattle, WA) presented a SNI clinical study known as ‘SLEUTH' (Safety of Lysis with Ultrasound in the Treatment of Intracerebral (ICH) and Intraventricular Hemorrhage (IVH) at the American Heart Association International Stroke Conference (San Antonio, TX).
› Verified 8 days ago
Dr. Allen Williams Ayres, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 620 John Paul Jones Cir, Portsmouth, VA 23708 Phone: 757-953-4298 Fax: 757-953-7350 | |
Dr. Shawn Dean Redding, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 620 John Paul Jones Cir, Portsmouth, VA 23708 Phone: 757-953-4335 | |
Emily Connell Kemner, DO Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: Naval Medical Center Portsmouth, 620 John Paul Jones Circle, Portsmouth, VA 23708 Phone: 518-522-0676 | |
Dr. Deborah Jane Wiese, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 620 John Paul Jones Cir, Portsmouth, VA 23708 Phone: 757-953-0399 Fax: 757-953-1007 | |
Dr. Kelly Ann Palumbo, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 620 John Paul Jones Cir, Portsmouth, VA 23708 Phone: 757-953-4601 | |
Syed Ahmed Hussain, Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 620 John Paul Jones Cir, Portsmouth, VA 23708 Phone: 757-953-5000 | |
Shorty Johansson, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 620 John Paul Jones Cir, Portsmouth, VA 23708 Phone: 757-953-0669 |